TNFSF10 and neoplasm: Thus, an interesting future direction for increasing PDT efficiency in melanoma could be linked to exogenous TRAIL addition to this line of therapy, which has the potential to take advantage of the recovered TRAIL sensitivity in melanoma cells and to induce selective tumor cell apoptosis.